A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications

Abstract Ergothioneine (ERGO) is a rare amino acid mostly found in fungi, including mushrooms, with recognized antioxidant activity to protect tissues from damage by reactive oxygen species (ROS) components. Prior to this publication, the biodistribution of ERGO has been performed solely in vitro us...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: William J. Behof, Clayton A. Whitmore, Justin R. Haynes, Adam J. Rosenberg, Mohammed N. Tantawy, Todd E. Peterson, Fiona E. Harrison, Robert B. Beelman, Wellington Pham
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/9f1da49055e5462fa3b225a7997b562e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9f1da49055e5462fa3b225a7997b562e
record_format dspace
spelling oai:doaj.org-article:9f1da49055e5462fa3b225a7997b562e2021-12-02T18:02:15ZA novel antioxidant ergothioneine PET radioligand for in vivo imaging applications10.1038/s41598-021-97925-w2045-2322https://doaj.org/article/9f1da49055e5462fa3b225a7997b562e2021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-97925-whttps://doaj.org/toc/2045-2322Abstract Ergothioneine (ERGO) is a rare amino acid mostly found in fungi, including mushrooms, with recognized antioxidant activity to protect tissues from damage by reactive oxygen species (ROS) components. Prior to this publication, the biodistribution of ERGO has been performed solely in vitro using extracted tissues. The aim of this study was to develop a feasible chemistry for the synthesis of an ERGO PET radioligand, [11C]ERGO, to facilitate in vivo study. The radioligand probe was synthesized with identical structure to ERGO by employing an orthogonal protection/deprotection approach. [11C]methylation of the precursor was performed via [11C]CH3OTf to provide [11C]ERGO radioligand. The [11C]ERGO was isolated by RP-HPLC with a molar activity of 690 TBq/mmol. To demonstrate the biodistribution of the radioligand, we administered approximately 37 MBq/0.1 mL in 5XFAD mice, a mouse model of Alzheimer’s disease via the tail vein. The distribution of ERGO in the brain was monitored using 90-min dynamic PET scans. The delivery and specific retention of [11C]ERGO in an LPS-mediated neuroinflammation mouse model was also demonstrated. For the pharmacokinetic study, the concentration of the compound in the serum started to decrease 10 min after injection while starting to distribute in other peripheral tissues. In particular, a significant amount of the compound was found in the eyes and small intestine. The radioligand was also distributed in several regions of the brain of 5XFAD mice, and the signal remained strong 30 min post-injection. This is the first time the biodistribution of this antioxidant and rare amino acid has been demonstrated in a preclinical mouse model in a highly sensitive and non-invasive manner.William J. BehofClayton A. WhitmoreJustin R. HaynesAdam J. RosenbergMohammed N. TantawyTodd E. PetersonFiona E. HarrisonRobert B. BeelmanWellington PhamNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-11 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
William J. Behof
Clayton A. Whitmore
Justin R. Haynes
Adam J. Rosenberg
Mohammed N. Tantawy
Todd E. Peterson
Fiona E. Harrison
Robert B. Beelman
Wellington Pham
A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
description Abstract Ergothioneine (ERGO) is a rare amino acid mostly found in fungi, including mushrooms, with recognized antioxidant activity to protect tissues from damage by reactive oxygen species (ROS) components. Prior to this publication, the biodistribution of ERGO has been performed solely in vitro using extracted tissues. The aim of this study was to develop a feasible chemistry for the synthesis of an ERGO PET radioligand, [11C]ERGO, to facilitate in vivo study. The radioligand probe was synthesized with identical structure to ERGO by employing an orthogonal protection/deprotection approach. [11C]methylation of the precursor was performed via [11C]CH3OTf to provide [11C]ERGO radioligand. The [11C]ERGO was isolated by RP-HPLC with a molar activity of 690 TBq/mmol. To demonstrate the biodistribution of the radioligand, we administered approximately 37 MBq/0.1 mL in 5XFAD mice, a mouse model of Alzheimer’s disease via the tail vein. The distribution of ERGO in the brain was monitored using 90-min dynamic PET scans. The delivery and specific retention of [11C]ERGO in an LPS-mediated neuroinflammation mouse model was also demonstrated. For the pharmacokinetic study, the concentration of the compound in the serum started to decrease 10 min after injection while starting to distribute in other peripheral tissues. In particular, a significant amount of the compound was found in the eyes and small intestine. The radioligand was also distributed in several regions of the brain of 5XFAD mice, and the signal remained strong 30 min post-injection. This is the first time the biodistribution of this antioxidant and rare amino acid has been demonstrated in a preclinical mouse model in a highly sensitive and non-invasive manner.
format article
author William J. Behof
Clayton A. Whitmore
Justin R. Haynes
Adam J. Rosenberg
Mohammed N. Tantawy
Todd E. Peterson
Fiona E. Harrison
Robert B. Beelman
Wellington Pham
author_facet William J. Behof
Clayton A. Whitmore
Justin R. Haynes
Adam J. Rosenberg
Mohammed N. Tantawy
Todd E. Peterson
Fiona E. Harrison
Robert B. Beelman
Wellington Pham
author_sort William J. Behof
title A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
title_short A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
title_full A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
title_fullStr A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
title_full_unstemmed A novel antioxidant ergothioneine PET radioligand for in vivo imaging applications
title_sort novel antioxidant ergothioneine pet radioligand for in vivo imaging applications
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/9f1da49055e5462fa3b225a7997b562e
work_keys_str_mv AT williamjbehof anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT claytonawhitmore anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT justinrhaynes anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT adamjrosenberg anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT mohammedntantawy anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT toddepeterson anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT fionaeharrison anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT robertbbeelman anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT wellingtonpham anovelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT williamjbehof novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT claytonawhitmore novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT justinrhaynes novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT adamjrosenberg novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT mohammedntantawy novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT toddepeterson novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT fionaeharrison novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT robertbbeelman novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
AT wellingtonpham novelantioxidantergothioneinepetradioligandforinvivoimagingapplications
_version_ 1718378945035894784